Protein Delivery In Vitro or In Vivo
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Biomedical Materials and Nanomedicine".
Deadline for manuscript submissions: closed (31 August 2020) | Viewed by 3102
Special Issue Editor
Special Issue Information
Dear Colleagues,
Many attempts at protein delivery are being made in the field of biotechnology, due to the developments in drug development, molecular science, and material engineering. This can be used to identify the role of organelles in cells, the role of various biomaterials made from the nucleus, and can sometimes be a way to control cell death and growth. In general, due to the size and solubility of proteins, it is not easy to deliver them into cells or organs, and many researchers have tried to overcome this by developing various nano-carrier systems. Approaches to the delivery of peptides or genes pose challenges such as integration, short lifetime, and easy degradation. Recently, nano-carrier systems with organic and inorganic components have been developed, and efforts are being made to deliver various protein hybrids to cells or desired organs using them. This Special Issue focuses on the recent advances in protein delivery using nano-carrier systems in vitro or in vivo. The goal is to stimulate the related research and contribute to the development of various drugs, the study of mechanisms for cell growth inhibition, and the development of material engineering science.
Prof. Dr. Tae-Jong Yoon
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- protein delivery
- nanoparticles
- targets
- material sciences
- encapsulation
- hybrid protein complex delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
